Ambulatory use of inhaled beta(2)-agonists for the treatment of asthma in Quebec : a population-based utilization review.

Abstract

STUDY OBJECTIVES To assess whether the utilization of inhaled short-acting beta(2)-agonists (ISAB) and inhaled long-acting beta(2)-agonists (ILAB) for the treatment of asthma was appropriate according to the 1996 Canadian Asthma Consensus Conference recommendations. DESIGN Population-based retrospective drug utilization review using pharmacists' billing… (More)

Topics

Cite this paper

@article{Blais2001AmbulatoryUO, title={Ambulatory use of inhaled beta(2)-agonists for the treatment of asthma in Quebec : a population-based utilization review.}, author={Rebecca Blais and J. P. Gregoire and Rachel Rouleau and Anna E. Cartier and Jean-Pierre Bouchard and Lucie Boulet}, journal={Chest}, year={2001}, volume={119 5}, pages={1316-21} }